These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21750093)

  • 1. Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression.
    Xie H; Xie PL; Wu XP; Chen SM; Zhou HD; Yuan LQ; Sheng ZF; Tang SY; Luo XH; Liao EY
    Cardiovasc Res; 2011 Nov; 92(2):296-306. PubMed ID: 21750093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omentin inhibits osteoblastic differentiation of calcifying vascular smooth muscle cells through the PI3K/Akt pathway.
    Duan XY; Xie PL; Ma YL; Tang SY
    Amino Acids; 2011 Nov; 41(5):1223-31. PubMed ID: 21082206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omentin-1 exerts bone-sparing effect in ovariectomized mice.
    Xie H; Xie PL; Luo XH; Wu XP; Zhou HD; Tang SY; Liao EY
    Osteoporos Int; 2012 Apr; 23(4):1425-36. PubMed ID: 21755404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose tissue-derived omentin-1 attenuates arterial calcification via AMPK/Akt signaling pathway.
    Xu F; Li FX; Lin X; Zhong JY; Wu F; Shan SK; Tan CM; Yuan LQ; Liao XB
    Aging (Albany NY); 2019 Oct; 11(20):8760-8776. PubMed ID: 31659144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The function and meaning of receptor activator of NF-κB ligand in arterial calcification.
    Nie B; Zhou SQ; Fang X; Zhang SY; Guan SM
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):666-671. PubMed ID: 26489619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6.
    Callegari A; Coons ML; Ricks JL; Rosenfeld ME; Scatena M
    J Vasc Res; 2014; 51(2):118-31. PubMed ID: 24642764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin promotes the osteoblastic differentiation of vascular smooth muscle cells from female mice by increasing RANKL expression.
    Liu GY; Liang QH; Cui RR; Liu Y; Wu SS; Shan PF; Yuan LQ; Liao EY
    Endocrinology; 2014 Feb; 155(2):558-67. PubMed ID: 24248461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Wnt/β-Catenin Pathway in the Arterial Medial Calcification and Its Effect on the OPG/RANKL System.
    Nie B; Zhang SY; Guan SM; Zhou SQ; Fang X
    Curr Med Sci; 2019 Feb; 39(1):28-36. PubMed ID: 30868488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway.
    Panizo S; Cardus A; Encinas M; Parisi E; Valcheva P; López-Ongil S; Coll B; Fernandez E; Valdivielso JM
    Circ Res; 2009 May; 104(9):1041-8. PubMed ID: 19325147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The P2Y
    Qian S; Regan JN; Shelton MT; Hoggatt A; Mohammad KS; Herring PB; Seye CI
    Atherosclerosis; 2017 Feb; 257():38-46. PubMed ID: 28038380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats.
    Mai QG; Zhang ZM; Xu S; Lu M; Zhou RP; Zhao L; Jia CH; Wen ZH; Jin DD; Bai XC
    J Cell Biochem; 2011 Oct; 112(10):2902-9. PubMed ID: 21618594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RANKL is a downstream mediator for insulin-induced osteoblastic differentiation of vascular smooth muscle cells.
    Yuan LQ; Zhu JH; Wang HW; Liang QH; Xie H; Wu XP; Zhou H; Cui RR; Sheng ZF; Zhou HD; Zhu X; Liu GY; Liu YS; Liao EY
    PLoS One; 2011; 6(12):e29037. PubMed ID: 22194983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway.
    Zhan JK; Tan P; Wang YJ; Wang Y; He JY; Tang ZY; Huang W; Liu YS
    Cardiovasc Diabetol; 2014 Nov; 13():153. PubMed ID: 25407893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
    Liu J; Xu K; Wen G; Guo H; Li S; Wu X; Dai R; Sheng Z; Liao E
    Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL.
    Di Bartolo BA; Cartland SP; Harith HH; Bobryshev YV; Schoppet M; Kavurma MM
    PLoS One; 2013; 8(9):e74211. PubMed ID: 24040204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 21 plays an inhibitory role in vascular calcification in vitro through OPG/RANKL system.
    Cao F; Liu X; Cao X; Wang S; Fu K; Zhao Y; Shen F; Liu J
    Biochem Biophys Res Commun; 2017 Sep; 491(3):578-586. PubMed ID: 28774557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Counteractive effects of omentin-1 against atherogenesis†.
    Watanabe K; Watanabe R; Konii H; Shirai R; Sato K; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
    Cardiovasc Res; 2016 May; 110(1):118-28. PubMed ID: 26790473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
    Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ
    Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR2 Promotes Vascular Smooth Muscle Cell Chondrogenic Differentiation and Consequent Calcification via the Concerted Actions of Osteoprotegerin Suppression and IL-6-Mediated RANKL Induction.
    Lee GL; Yeh CC; Wu JY; Lin HC; Wang YF; Kuo YY; Hsieh YT; Hsu YJ; Kuo CC
    Arterioscler Thromb Vasc Biol; 2019 Mar; 39(3):432-445. PubMed ID: 30626205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.